Research at Biogen Source: Biogen Alzheimer’s patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai shows.  The Japanese drugmaker and its partner Biogen last week released an additional analysis of clinical trials of the monoclonal antibody drug, which is also known as lecanemab. Alzheimer’s disease continued toContinue Reading

The COVID pandemic risks lasting damage to adult social care

Comeback Images/Shutterstock Three years have passed since the UK government implemented emergency legislation in response to the COVID pandemic. The Coronavirus Act 2020 made amendments to laws affecting many aspects of society, including the duties and powers incumbent on England’s local authorities to provide adult social care under the CareContinue Reading

New wrist-worn device can quickly tell if you're having a heart attack – it could save many lives

pixelheadphoto digitalskillet/Shutterstock Scientists have developed a wrist-worn device that could revolutionise treating heart attacks by speeding up diagnosis – without the need to draw blood (the current method). Over 700,000 people visit A&E in England and Wales because of chest pain. And they account for 25% of medical admissions toContinue Reading